TPG Capital-backed BVI completed the acquisition of Benz Research & Development.

TPG Capital-backed BVI, a diversified company in ophthalmology, completed the acquisition of Benz Research & Development, a contact lenses manufacturer. Financial terms were not disclosed. "Adding Benz to our company is quite strategic for BVI as it brings us world-class lens material capabilities. Furthermore, the proprietary IOL molding technology will allow us to increase materially the scale of our IOL production. When we met Pat Benz several years ago, it quickly became evident that a partnership together would be a great next step towards BVI’s expansion aspirations. We welcome the Benz team to the BVI family," Shervin Korangy, BVI President and CEO.